DTwP-HBV-HIB vaccine - Biological E Ltd

Drug Profile

DTwP-HBV-HIB vaccine - Biological E Ltd

Alternative Names: ComBe Five; DTwP-rHepB-HIB - Biological C

Latest Information Update: 26 Sep 2016

Price : $50

At a glance

  • Originator Biological E Limited
  • Class Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 01 Sep 2016 Biological E. Limited initiates enrolment in a clinical trial in Healthy volunteers (In infants, prevention) in Vietnam (NCT02904213)
  • 07 Feb 2014 Launched for Hepatitis B in India (Parenteral)
  • 01 Jan 2011 Launched for Haemophilus infections in India (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top